Optimize Value in a Complex Pricing and Access Environment

The pace of innovation in biopharmaceuticals is rapid and the impact on human health has been profound. The most successful companies have robust R&D and commercial capabilities to thrive in an increasingly value-based health care environment. BHA supports biopharma innovators where value is only emerging– precision medicines and high value specialty and orphan drugs. BHA supports companies in making critical business decisions during this exciting—and unprecedented—time for a global industry poised to deliver outcomes that create proven value for patients.

Optimize Value in a Complex Pricing and Access Environment

The pace of innovation in biopharmaceuticals is rapid and the impact on human health has been profound. The most successful companies have robust R&D and commercial capabilities to thrive in an increasingly value-based health care environment. BHA supports biopharma innovators where value is only emerging– precision medicines and high value specialty and orphan drugs. BHA supports companies in making critical business decisions during this exciting—and unprecedented—time for a global industry poised to deliver outcomes that create proven value for patients.

Focus Areas

  • Precision Medicines
  • Specialty Drugs
  • Orphan Drugs
  • Cell and Gene Therapy
  • 505(b)2 Approval Pathway

Solutions

  • Companion Diagnostics Global Commercialization Roadmap
  • Pricing Strategy
  • Market Opportunity Assessment
  • Evidence Development Strategy
  • Health Economic Analysis

Therapeutic Areas

  • Hematology | Oncology
  • Pain | CNS | Neuromuscular | Neurologic Disorders
  • Immune Disorders | Inflammation
  • Cardiovascular Disease
  • Enzyme Deficiency Disorders
  • Gastrointestinal | Hepatic Disease
  • Renal/Metabolic | Endocrine
  • Infectious Disease
  • Cell and Gene Therapies

Case Studies

Global Market Access Strategy for Companion Diagnostic Test

Health Economic Analysis and Publication Support for Specialty Drug

Health Economic Analysis and Publication Support for Specialty Drug

Market Opportunity Assessment for Orphan Drug in Rare Ocular Malignancy

Market Opportunity Assessment for Orphan Drug Rare Ocular Malignancy Case Study

Transaction Preparation: Novel Biopharmaceutical Planning U.S. Market Entry

Case Study - Transaction Preparation - Novel Biopharmaceutical Planning US Market Entry

Create. Navigate. Grow. Achieve.